F Maloisel
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 3
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Hervé Avet‐Loiseau (1 shared paper)Nadine Morineau (1 shared paper)Pascaline Talmant (1 shared paper)Marie-Josée Rapp (1 shared paper)Arnaud Jaccard (1 shared paper)Christophe Brigaudeau (1 shared paper)Jianyong Li (1 shared paper)Thierry T.F. Facon (1 shared paper)
- Journals
- Leukemia (1 paper)Journal of Clinical Oncology (1 paper)Médecine et Maladies Infectieuses (1 paper)Journal de Pharmacie Clinique (1 paper)PubMed (2 papers)
- Partner nations
- FranceUnited KingdomItaly
In The Last Decade
F Maloisel
7 papers receiving 394 citations
Peers
Comparison fields: 5 of 39
- Genetics 124
- Hematology 128
- Immunology 135
- Reproductive Medicine 48
- Oncology 128
Countries citing papers authored by F Maloisel
This map shows the geographic impact of F Maloisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Maloisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Maloisel more than expected).
Fields of papers citing papers by F Maloisel
This network shows the impact of papers produced by F Maloisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Maloisel. The network helps show where F Maloisel may publish in the future.
Co-authors
The 25 scholars most cited alongside F Maloisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. | 1998 | 168 |
| 2 | 1996 | 140 | |
| 3 | 2003 | 88 | |
| 4 | 1995 | 6 | |
| 5 | Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot study. | 1991 | 3 |
| 6 | 2012 | 2 | |
| 7 | La radio-immunothérapie des cancers | 2005 | 1 |
About F Maloisel
F Maloisel is a scholar working on Reproductive Medicine, Pathology and Forensic Medicine, Genetics, Hematology and Surgery, having authored 7 papers that have together received 408 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Heparin-Induced Thrombocytopenia and Thrombosis (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Genetics (124 citations), Hematology (128 citations), Immunology (135 citations), Reproductive Medicine (48 citations) and Oncology (128 citations). F Maloisel has collaborated with scholars based in France, United Kingdom and Italy. Frequent co-authors include Hervé Avet‐Loiseau, Nadine Morineau, Pascaline Talmant, Marie-Josée Rapp, Arnaud Jaccard, Christophe Brigaudeau, Jianyong Li, Thierry T.F. Facon, Franck Trimoreau and Jean‐Luc Harousseau. Their work appears in journals such as Leukemia, Journal of Clinical Oncology, Médecine et Maladies Infectieuses, Journal de Pharmacie Clinique and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.